Brief: Evoke Pharma Announces FDA Orange Book Listing Of U.S. Patent For Gimoti
June 8 (Reuters) - Evoke Pharma Inc EVOK.O :
* EVOKE PHARMA ANNOUNCES FDA ORANGE BOOK LISTING OF U.S.
PATENT
FOR GIMOTI®
* EVOKE PHARMA INC - PATENT COVERS METHODS OF USE FOR NASAL
DELIVERY OF METOCLOPRAMIDE FOR TREATMENT OF GASTROPARESIS
* EVOKE PHARMA INC - NEW PATENT IS NOW LISTED IN FDA'S
ORANGE BOOK
AND CARRIES A PATENT TERM TO AT LEAST 2029.
Source text for Eikon: ID:nGNX3KYphL
Further company coverage: EVOK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evoke Pharma
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Evoke Pharma Q3 sales rise 61%, expects QOL Medical acquisition to close in Q4 2025
Brief: Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
Evoke Pharma Inc reports results for the quarter ended June 30 - Earnings Summary